Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report) shares were up 2% on Wednesday . The company traded as high as $13.22 and last traded at $13.15. Approximately 1,794,287 shares traded hands during trading, an increase of 431% from the average daily volume of 337,931 shares. The stock had previously closed at $12.89.
Silverback Therapeutics Trading Up 0.2 %
The business’s 50 day simple moving average is $12.19 and its two-hundred day simple moving average is $12.97. The firm has a market capitalization of $455.41 million, a PE ratio of -5.22 and a beta of 0.60.
About Silverback Therapeutics
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Articles
- Five stocks we like better than Silverback Therapeutics
- Market Cap Calculator: How to Calculate Market Cap
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
